Background: African American men with hypertension (HTN) in low socioeconomic urban environments continue to achieve poor rates of HTN control.
D
espite early onset and high prevalence of hypertension (HTN) in African American men, their rates of treatment and control are lower and rates of early target organ damage higher than those of whites. 1 Treatment of HTN lowers blood pressure (BP), improves HTN control, and decreases target organ damage. [2] [3] [4] To our knowledge, this is the first hypertension clinical trial specifically targeting high risk, underserved young urban African American men. [5] [6] [7] [8] [9] [10] This article describes changes in HTN care utilization, behavioral factors, physiologic outcomes, and mortality during 5 years.
Methods

Study Population
The study population included 309 hypertensive African American men residing in inner city Baltimore. All subjects had systolic BP Ն140 mm Hg or diastolic BP Ն90 mm Hg on two separate occasions or were on antihypertensive medication. Men who were on dialysis, had acute, terminal, or serious mental illness, or were participating in another HTN study were excluded. At baseline, the mean age of the sample was 41 Ϯ 6 years. Only 60% had high school diploma or equivalent, 27% were employed parttime or full-time, and 71% had annual income less than $10,000. The majority (58%) had never married and 64% reported history of incarceration. Mean (ϮSD) systolic BP/diastolic BP was 147 Ϯ 20 mm Hg/99 Ϯ 15 mm Hg. Fifty-three percent were on antihypertensive medication, and of these 19% had controlled BP (Ͻ140/90 mm Hg). Baseline demographic and clinic characteristics, study design and methods, 11 and outcomes at 3 years 12 were reported previously.
Study Protocol
This 5-year randomized clinical trial compared the effect of a more intensive to a less intensive intervention. After approval by the Johns Hopkins Institutional Review Board, eligible men who gave written informed consent were assessed for baseline characteristics and randomly assigned to the more intensive (n ϭ 157) or less intensive (n ϭ 152) group. Men in the more intensive group received comprehensive HTN care by a nurse practitioner (NP)/community health worker (CHW)/physician (MD) team, with counseling regarding the importance of adherence to treatment recommendations and appointment keeping. 13 The NP visits were scheduled every 1 to 3 months as needed. In year 1, the CHW made a home visit to engage and assist the person identified by the participant as the individual providing them with support regarding health and nonhealth matters. Subsequent CHW visits were based on the men's needs, with referrals related to social services, job training, and housing. Barriers to care and treatment were addressed by the team and free medication provided at visits. The NP adjusted medication according to a Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) guideline-based protocol beginning with progressive titration of losartan (50 to 100 mg) and losartan/HCTZ (50/12.5 to 100/25 mg).
14 If indicated, the study MD or participant's primary care provider provided consultation. 13 The MD provided consultation and participated in case discussions. Table 1 lists the trial intervention components. Men in the less intensive group were referred to HTN care sources in the community. On enrollment both groups received education about benefits of controlling HTN. They were reminded of the importance of HTN control every 6 months by telephone call and at annual research visits when behavioral and physiologic outcomes were evaluated and informed consent for study continuation obtained. Men were paid $25 to $100 for attending annual visits.
Measurements
Men in both groups were seen annually. Trained Outpatient General Clinical Research Center staff, blinded to group assignment, using an appropriately sized cuff after the participant was seated for 5 min, obtained three BP measurements at 1-min intervals with a Hawksley random zero sphygmomanometer (WA Baum Co., Inc., New York, NY). 15, 16 The second and third BP measurements were averaged. The BP control was defined as BP Ͻ140/90 mm Hg.
Transthoracic echocardiography was performed by a trained sonographer. Left ventricular mass (LVM) was calculated by a cardiologist blinded to participant characteristics. The two-dimensional 5/6 area-length method was used because of its potential for generating greater accuracy and reproducibility than M-mode methods. 17 Two measurements were made and the mean was used. The LVM was indexed to body surface area (BSA) and left ventricular hypertrophy (LVH) was defined as LVM/ BSA Ͼ131g/m 2 . 18 Target organ damage at baseline has been described in detail. 19 Serum creatinine, total cholesterol, and HDL cholesterol (in milligrams per deciliter) were measured by standard procedures through Quest Laboratories. Diabetes was defined as diagnosis of diabetes or random serum glucose Ͼ200 mg/dL. Illicit drug use was determined by urine drug screen. Staff interviewed participants about sociodemographic and behavioral risk factors, using items from the National Health Interview Survey, 20 and Hill-Bone Compliance Scale, 21 and HTN care utilization (ie, current HTN care provider, antihypertensive medications).
Analysis
To determine intervention effect, differences in BP and LVM change scores between groups were compared using unpaired t tests and within groups using paired t tests. The effect of other variables on BP response profile was measured with Random Effects models using cubic splines to model the underlying shape of response over time. The 2 tests assessed changes in categorical variables. Exploratory multiple regression models of continuous dependent variables, mean systolic BP and mean diastolic BP, and multivariate logistic model of categorical variable, HTN control (Ͻ140/90 mm Hg), included the following relevant sociodemographic, behavioral, and HTN care independent variables: intervention group, gender, age in years, education level, employment status, insurance status, baseline BP status (systolic BP, diastolic BP, or HTN control corresponding with dependent variable), HTN medication prescription, Hill-Bone Compliance Scale subscales and sum scores, body mass index in kilogram per meter squared, illicit drug use by urine screen, cigarette smoking status, and self-reported salt intake. Hierarchical regression analysis assessed LVM change, while controlling for relevant variables. Kaplan-Meier curves of survival estimates compared time-to-event for progression of renal impairment (ie, serum creatinine, urine microalbuminto-creatinine ratio). Progression was defined relative to each individual's baseline value and measured using the following models: (1) 50% increase in serum creatinine and (2) progression of urine microalbumin-to-creatinine ratio among categories defined as normal (0 to 20 mg/g), microalbuminuria (20 to 200 mg/g), and gross proteinuria (Ͼ200 mg/g). The log-rank test for survival estimates was used to test for group differences.
Results
Follow-up and Mortality Rates
Tracking and follow-up procedures 22 resulted in follow-up rates at or exceeding 89% during 5 years for both groups, when rates were calculated to account for inability to assess men who had died, been incarcerated, or moved out of state ( Fig. 1) . At 5-year follow-up, 17% of men were deceased, with no significant difference in mortality rate or cause of death between groups ( Table 2 ). Cause of death was determined by death certificate review by two independent investigators. Narcotic or alcohol intoxication accounted for 36% and cardiovascular and cerebrovascular disease, 26% of deaths.
Effects of Interventions on BP and BP Control
At baseline BP control rates were 17% in the more intensive and 21% in the less intensive groups ( Table 3) . The BP control rates increased in both groups with greater control rates in the more intensive group, compared to baseline at all points, although the between-group significant difference in BP control (more intensive 44%, less intensive 31%, P ϭ .05) at 3 years, was not sustained to 5 years.
Systolic and diastolic BP were lower at follow-up for both groups, with exception of increased systolic BP at 3 and 4 years in the less intensive group (Table 4) . Withingroup decrease from baseline was statistically significant for systolic BP in the more intensive group at 1, 3, and 4 years (P Ͻ .001 for all). Decrease from baseline was significant for diastolic BP in both groups at 1 and 2 years and the more intensive group at all points. When analyses included only men who participated at 5 year follow-up (n ϭ 200), a beneficial effect of the more intensive intervention was seen for systolic and diastolic BP lowering at 3 and 4 years, compared to the less intensive intervention. Random Effects models examined whether differences in , and 5 years, respectively. ‡Accounting for those who were deceased (n ϭ 5, 9, 17, 22, 28), incarcerated (n ϭ 9, 9, 13, 14, 16), had moved out-of-state (n ϭ 3, 4, 4, 4, 6), or were in a long-term care facility (n ϭ 1, 1, 2, 2, 2) at 1, 2, 3, 4, and 5 years, respectively. §Statistically significant between group difference for sample follow-up, P Ͻ .05.
systolic and diastolic BP responses to interventions could be explained by patient characteristics. Of time-dependent variables, only having a physician or NP for HTN care had a significant effect after controlling for general response profiles in the intervention groups. However, an interaction term between this effect and the overall treatment effect was not significant, indicating the effect of having a physician or NP for HTN care, although significant, was not altered in any way by the more intensive intervention. Men who died during the study had significantly higher baseline BP (151/102 mm Hg) compared to those participating in 5-year follow-up (142/94 mm Hg) (P Ͻ .01). Significant predictors of systolic BP at 5 years included baseline systolic BP (␤ ϭ 0.25, P ϭ 0.043) and the Hill-Bone Compliance Scale medication-taking subscale score (␤ ϭ 1.88, P ϭ 0.020). Significant predictors of diastolic BP at 5 years included baseline diastolic BP (␤ ϭ 0.28, P ϭ 0.007) and the Hill-Bone Compliance Scale medication-taking subscale score (␤ ϭ 0.96, P ϭ 0.042).
None of the variables included in the model were significant predictors of HTN control at 5 years.
Changes in LVM
At baseline there were no differences between the more intensive and less intensive groups in prevalence of echocardiographic LVH (19.8% in more intensive v 18.6% in less intensive group, P ϭ .85) among men who attended baseline and 5-year follow-up examinations with LVH data available for both examinations (n ϭ 139). At 5 years, LVH prevalence in the more intensive group was lower compared to the less intensive group (37% v 56%, P ϭ .02). Among men without LVH at baseline, progression to development of LVH was lower at 5 years in the more intensive group compared to the less intensive group (19% v 37%, P ϭ .02).
Changes in Serum Creatinine and Proteinuria
At baseline there were no differences between the more intensive and less intensive groups in mean serum creatinine (1.27 mg/dL in more intensive and 1.29 mg/dL in less intensive group, P ϭ .89) or prevalence of microalbuminuria (36% in more intensive and 45% in less intensive group, P ϭ .14). Annual incidence rates of 50% increase in serum creatinine, compared with the lowest previously recorded measure, were nearly identical in the groups (more intensive, 7.8%; less intensive, 7.7%). The KaplanMeier curves revealed that the proportion of men remaining free of 50% increase in serum creatinine during follow-up was more intensive 66% and less intensive 68% (hazard ratio 1.01, P Ͻ .97). Annual incidence rates of increase in proteinuria status, over lowest previously recorded measure, were similar in the two groups (more intensive, 13%; less intensive, 14%). The Kaplan-Meier curves revealed that the proportion of men remaining free Note: AIDS was noted as a significant contributing condition on the death certificates of 5 men (more intensive, n ϭ 3; less intensive, n ϭ 2) with other primary causes of death. of increase in proteinuria status was more intensive 48% and less intensive 52% (hazard ratio 1.09, P ϭ .63).
Changes in Demographics, Cardiovascular, and Lifestyle Risk Factors, and HTN Care Utilization
The proportion of men who were unemployed, with annual income Ͻ$10,000, and no health insurance was high in both groups at baseline, decreased in both groups over time, and was not statistically different between groups. During the course of the study, maximum improvements in sociodemographic risk factors were seen as follows: unemployed (54% more intensive, 46% less intensive at 4 years), with annual income Ͻ$10,000 (50% more intensive, 52% less intensive at 5 years), and no health insurance (26% more intensive, 25% less intensive at 3 years).
The high prevalence of illicit drug use (by urine toxicity screening) at baseline (40% more intensive, 44% less intensive) was unchanged in both groups. The proportion of men reporting cigarette smoking (84% more intensive, 76% less intensive at baseline; 68% more intensive, 67% less intensive at 5 years) and eating salty food "all or most of the time" (56% more intensive, 49% less intensive at baseline; 18% more intensive, 30% less intensive at 5 years) decreased significantly from baseline to subsequent follow-up in both groups, with no significant differences between groups. Although the proportion of men with elevated serum total cholesterol (TC Ͼ200 mg/dL) (32% more intensive, 30% less intensive at baseline) was unchanged, both groups demonstrated significant decreases in proportion of men with low serum HDL-cholesterol (Ͻ35 mg/dL) (28% more intensive, 36% less intensive at baseline; 9% more intensive, 11% less intensive at 5 years). Prevalence of diabetes increased at follow-up (7% more intensive, 12% less intensive at baseline; 15% more intensive, 18% less intensive at 5 years), and over one-half of men in both groups were either overweight (body mass index [BMI] 25 to 30 kg/m 2 ) (30% more intensive, 31% less intensive at baseline) or obese (BMI Ͼ30 kg/m 2 ) (26% more intensive, 26% less intensive) at baseline, with no significant change during follow-up. There were no significant differences in changes in these cardiovascular risk factors during follow-up between the two groups.
The proportion of men reporting having an MD or nurse for HTN care increased in the more intensive group (P Ͻ .05), but remained unchanged in the less intensive group (67% more intensive, 72% less intensive at baseline; 92% more intensive, 65% less intensive at 5 years). The proportion of men reporting being on antihypertensive medications increased significantly in both groups (35% more intensive, 35% less intensive at baseline; 90% more intensive, 63% less intensive at 5 years) (P Ͻ .05). The more intensive group showed significant improvement in both of these HTN care utilization variables when compared to the less intensive group (P Ͻ .001).
Compliance With HTN Care Behaviors
There was a positive trend toward improved compliance with HTN care behaviors, including sodium reduction, medication taking, and appointment keeping during follow-up in both groups. The total compliance score improved significantly within groups from baseline at 2, 3, and 4 years in the more intensive group and 3 years in the less intensive group (P Ͻ .05). A beneficial effect of the more intensive intervention was seen in total compliance score at 2, 3, and 4 years, sodium subscale at 2 and 3 years, medication subscale at 4 years, and appointment subscale at 3 and 4 years (all P Ͻ .05).
Discussion
Despite the perception that African American men are difficult to engage and follow, in this study, tracking and follow-up rates were exceptionally high, exceeding 89% of available men during 5 years. These rates reflect the persistent and systematic efforts of the study staff, who were exceptionally committed and flexible in individualizing care. 22 Although follow-up rates were greater among the more intensive group at 1, 3, and 5 years, after accounting for those who died or were incarcerated, the differences were no longer significant. The mortality rate within this group of young men was extremely high. However, the study did not have sufficient power to detect group differences in mortality. Mortality due to substance abuse and cardiovascular disease may not be surprising given baseline morbidity; however, these rates illustrate a major societal and public health problem. Improved access to substance abuse treatment, as well as comprehensive healthcare and preventive services, may help to reduce this alarming mortality rate.
The improvement in systolic and diastolic BP and BP control rate that occurred in both more intensive and less intensive groups at most points from baseline to final 5 years are major findings of this study. These changes were statistically and clinically significant within groups, and between the more intensive and less intensive groups at 3 years. The BP improvements remained greater in the more intensive than the less intensive group throughout the study, although difference between groups was no longer significant at 5 years. A similar lack of significant differences between intervention groups has been reported in other HTN studies. 23 Nonetheless, participation in the study was an intervention in and of itself, illustrating the importance of participant's motivation and self-selection to enroll and continue in the study. The protocol required intensive tracking and data collection, including an annual visit lasting approximately 3 hours and phone calls every 6 months to update contact information and obtain data on health care utilization. Importantly, by 5 years, the sample size had decreased due to high rates of mortality and incarceration, which limited study power to detect group differences.
There may have been a tapering effect of the more intensive treatment during the course of the study. The intervention team was nonjudgmental and encouraged the men to talk about issues of concern other than HTN. The CHWs assisted the men with HTN care behaviors, job skills training, and accessing drug rehabilitation. At 3 years, CHW home visits were suspended due to decreased interest and availability among support persons. The percentage of more intensive group men declining CHW home visit increased from 17% in year 1 to 51% in year 3, likely because the men had access to the NP or CHW by telephone or clinic visits. These individualized interactions also influenced the median number of NP visits, which decreased from six visits in year 1 to three visits in years 4 and 5. It is possible that the decrease in NP visits may have been related to "fatigue" during the 5-year study as the "uniqueness" wore off. There probably was a need for a modified or an intensified intervention in the last 2 years.
We previously reported the high prevalence of renal and cardiac target organ damage 19 and now demonstrate rapid progression of renal and cardiac target organ damage in both groups. Although there were no group differences in progression of renal damage, the more intensive group did show less hypertrophic left ventricular remodeling than the less intensive group at 5 years. The more intensive group reduced the rate of progression to LVH, which has been identified as an independent predictor of cardiovascular events. 24, 25 The mechanism leading to this reduced progression to LVH was likely a combination of better BP control and greater use of angiotensin-receptor blockade with losartan. The LIFE study showed that losartan can slow the progression of LVH in hypertensive patients. 24 Rates of receiving HTN care and being on antihypertensive medications improved and there was a positive trend toward improvement in HTN care compliance, including sodium reduction, medication taking, and appointment keeping in both groups. However, the improvement in overall HTN care compliance, which was greater in the more intensive group at 2, 3, and 4 years, was lost by 5 years. Employment, income, and health insurance status improved in both groups during 5 years, as did cigarette smoking and salt consumption. There were no improvements in cholesterol or BMI levels. The risk factors and complications, in addition to the primary outcome of BP, requiring interventions were numerous and complex exceeding the capacity of the study staff and budget. Although we made efforts to be comprehensive in the more intensive group, we were unable to effect significant change in dyslipidemia, diabetes, and weight loss concurrently despite their importance. 25 The key findings of this study merit further dissemination to the practice and policy communities. Particularly at a time when reducing health disparities and costs of delivering care are urgent priorities to all segments of society, the methods of this study team to identify, recruit, track and follow, and improve HTN care and control are important. This non-traditional model with multiple, creative approaches established patient-centered relationships and included problem-solving in the context of the mens' lives to improve HTN control. Additionally, the intervention team demonstrated commitment to the mens' health and flexibility by seeing the men when they presented and reaching out to re-engage them in treatment when necessary.
In conclusion, this study indicates that a well-planned, culturally appropriate educational/behavioral intervention delivered by a NP/CHW/MD team, can successfully recruit and maintain young African American men with HTN in care and improve HTN control during 5 years. Both the more intensive and less intensive interventions contributed to positive results. Further research to probe into this phenomenon (ie, improvement in both intervention groups) as well as to improve individualized HTN care and total CV risk management in this high risk, underserved population is needed. Future studies to improve care and reduce mortality in high risk underserved populations, such as this sample, will need to address compliance with evidence-based practice guidelines factors at the patient, provider, and healthcare organization levels, 26 as well as address factors such as lack of health insurance and substance abuse treatment, at the societal level.
